Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging

Project description

Radiomics analysis in ovarian cancer

High-grade serous ovarian cancer (HGSOC) is characterised by high heterogeneity and early resistance to chemotherapy, posing a significant clinical challenge. Studying HGSOC requires multiple sampling approaches that are non-invasive yet capture the functional and morphologic features of the disease. The ERC-funded MR O MICS project proposes to explore radiomics, an advanced imaging analysis technique that extracts quantitative parameters from medical images with respect to tumour morphology and functional characteristics. The research team aims to combine radiomics with histology and provide important insight into underlying HGSOC biology, paving the way towards better disease understanding and improved treatment strategies.

Objective

High-grade serous ovarian cancer (HGSOC) is the most common subtype of ovarian cancer. The early rapid onset of chemoresistance poses a major clinical challenge. Recent research highlighted high tumor heterogeneity (TH) and identified key mutational signatures that associate with prognosis and may aid in individualized treatment selection. Since HGSOC often presents with multisite disease and distinct populations of malignant cells, multi-region analysis of multimodal data is essential to study HGSOC. Single time point, single site biopsies cannot assess entire tumor while multiple biopsies at several time points are not feasible in clinical routine. Limitations of invasive sampling may be addressed with non-invasive imaging that captures morphologic and functional information about the entire tumor in space and, if repeated, in time. Radiomics has the potential for whole tumour virtual sampling using a single or serial non-invasive examinations in place of biopsies. To date, no study has evaluated the value of radiomics at macroscopic (in vivo 1.5T/3TMRI) and microscopic (ex vivo 9.4TMRI) scales to better understand the black box of radiomics features (explainable radiomics) or examine whether radiomics habitats are underpinned by tumour biology to provide a better insight into TH of HGSOC. Specifically, in this project, I will implement a model to capture imaging-based TH with multiscale radiomics approach by obtaining the mirror tumor image at in vivo MRI, ex vivo MRI and at histology. I will evaluate if imaging-based TH reflects underlying tumor histology by testing associations with imaging features and tumor-stroma proportion, infiltrative lymphocytes density and HRD status. Finally, I will unravel HGSOC TH biology through habitat imaging combined to an integrated Multi-O-Mics approach. Successful completion of this proposal will lead to a comprehensive characterization of HGSOC TH which will be then accessible non-invasively through radiomics.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) ERC-2022-STG

See all projects funded under this call

Host institution

INSTITUT REGIONAL DU CANCER DE MONTPELLIER
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 537 000,00
Address
208 AVENUE DES APOTHICAIRES
34298 Montpellier
France

See on map

Region
Occitanie Languedoc-Roussillon Hérault
Activity type
Research Organisations
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 537 000,00

Beneficiaries (2)

My booklet 0 0